Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy (NCT02304913) | Clinical Trial Compass
RecruitingNot Applicable
Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy
Germany75 participantsStarted 2015-01-01
Plain-language summary
This randomized controlled trial aims to investigate hypoglossal acupuncture in comparison to sham acupuncture and standard medical treatment (dietary recommendations) in the treatment of dysgeusia in cancer patients undergoing chemotherapy.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Initial treatment with platinum-containing or taxane-based CTX (regardless of the the length of the CTX cycle)
* Senological, gynecological or internistic tumors
* Phantogeusia (on average ≥4 NRS)
* Willingness to participate in the study and written informed consent
Exclusion Criteria:
* Severe stomatitis
* Dysgeusia before the CTX based on neurological diseases, diabetes, or the ingestion of drugs with taste disorders as side effects
* Leucopenia/neutropenia
* Intake of anticoagulants
* Smoking
* Severe physical or mental comorbidity (due to which the patient is unable to participate in the study)
* Participation in other CAM treatments within the integrative oncology care
* Participation in other studies on the effectiveness of interventions for oral complications